Biomea Fusion, Inc. - Common Stock — movimiento de fondos (NASDAQ:BMEA)

Financials

Flujo de caja de las actividades operativas -35.44 M-62.42 M-96.59 M-119.89 M-70.37 M -56.37 M Flujo de caja de las actividades de inversión -33.35 M27.34 M-2.22 M-362 K-362 K — Flujo de caja de las actividades financieras 153.19 M1.24 M163.8 M1.67 M67.9 M — Flujo de caja libre -35.44 M-62.42 M-96.59 M-119.89 M-70.37 M -56.37 M

Noticias

Citizens inicia cobertura de Biomea Fusion por potencial en diabetes

Biomea reporta resultados positivos en ensayo de diabetes tipo 1

Biomea Fusion, Inc. (BMEA) Discusses Menin Inhibition Mechanism and Therapeutic Potential in Diabetes Transcript

Biomea Fusion, Inc. (BMEA) Discusses Phase I Data and Clinical Potential of Oral GLP-1 Receptor Antagonist for Obesity Transcript

Biomea Fusion, Inc. (BMEA) Presents at 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026 - Slideshow (NASDAQ:BMEA) 2026-03-16

Biomea Fusion, Inc. (BMEA) Presents at The Citizens Life Sciences Conference 2026 - Slideshow (NASDAQ:BMEA) 2026-03-12

Biomea Fusion, Inc. (BMEA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:BMEA) 2026-01-16

Biomea Fusion, Inc. (BMEA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Rodman & Renshaw inicia cobertura de Biomea Fusion con calificación de Compra

Rodman & Renshaw initiates Biomea Fusion stock with Buy rating

Biomea Fusion detalla planes para fármacos contra diabetes y obesidad en 2026